Back to results
US 2021/0079093 A1Published application
Methods for achieving therapeutically effective doses of anti-cd47 agents
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsStephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska, Anne Kathrin Volkmer, Jens-Peter Volkmer, Irving L. Weissman
Life of this patent
Estimating the term…
Abstract
Methods are provided for treating a subject with a therapeutic dose of anti-CD47 agent by administering a primer agent prior to administering a therapeutically effective dose of an anti-CD47 agent to the subject.
Claims20
A method for treating a human subject with cancer, the method comprising:
- (a) administering a sub-therapeutic dose of from 0.1 mg/kg to 10 mg/kg of an anti-CD47 antibody, wherein the sub-therapeutic dose is sufficient to increase production of reticulocytes;
- and
- (b) administering a therapeutically effective dose of an anti-CD47 antibody;
- wherein step (b) is performed in a range of from 5 to 9 days after beginning step (a).
1 more element
A method for treating a human subject with cancer, the method comprising:
- (a) administering a sub-therapeutic dose of 1 mg/kg of an anti-CD47 antibody, wherein the sub-therapeutic dose is sufficient to increase production of reticulocytes;
- and
- (b) administering a series of therapeutically effective doses of an anti-CD47 antibody of escalating concentration at doses from 10 mg/kg to about 30 mg/kg;
- wherein step (b) is administered semi-weekly, starting 8 days after beginning step (a).
1 more element
A method for treating a human subject with cancer, the method comprising:
- (a) administering a series of two sub-therapeutic dose of 1 mg/kg of an anti-CD47 antibody, wherein the sub-therapeutic dose is sufficient to increase production of reticulocytes;
- and
- (b) administering a series of therapeutically effective doses of an anti-CD47 antibody of escalating concentration at doses from 10 mg/kg to about 30 mg/kg;
- wherein step (b) is administered semi-weekly, starting 8 days after beginning step (a).
1 more element
Dependencies are inferred from the claim text.